Mapping the spatial progression of brain growth and neuroinflammatory responses

Mental Clarity & Brain Health
1

Abstract:

Mapping multiple layers of omics data across space and time allows for a deeper understanding of the processes governing brain maturation^(1), cell differentiation, regional specialization, and pathological changes. In this study, we utilized spatial tri-omic methods—integrating ATAC–RNA–protein and CUT&Tag–RNA–protein sequencing—along with multiplexed immunofluorescence (CODEX) to track the dynamic structural changes occurring during brain development and neuroinflammation. We established a spatiotemporal tri-omic reference for the mouse brain from birth (P0) to three weeks (P21), drawing parallels with human brain development. Within the cortex, we discovered that chromatin accessibility for specific layer-defining transcription factors persists over time and expands spatially. In the corpus callosum, we identified localized chromatin priming of genes related to myelin and found that specific projection neurons help synchronize axon development and myelination. Using a lysolecithin-induced neuroinflammation model, we uncovered molecular pathways that overlap with developmental stages. Microglia demonstrated both shared and unique signatures for initiating and resolving inflammation, with temporary activation detected at the site of injury as well as in distant areas. Collectively, this research highlights both universal and distinct mechanisms in brain growth and inflammation, offering a comprehensive dataset for studying neural development, physiology, and disease.

5 Likes
2

I wonder how these findings might be put into practice.

3

That’s an excellent point, OP. The significance of this study lies in how it establishes a framework for using spatial multi-omic analysis in both basic development and clinical research. By identifying exactly how chromatin, RNA, and proteins interact across different regions and timeframes, we can better understand the specific origins of neuroinflammation in conditions like MS, Alzheimer’s, or during recovery from injury, rather than just observing the end result.

From a practical standpoint, this level of detail could inform more precise treatments. For instance, it could highlight specific microglial or astrocytic pathways for regional modulation or pinpoint epigenetic markers linked to harmful inflammation.

While currently at the preclinical stage, these techniques might eventually evaluate how experimental drugs—such as anti-inflammatory peptides, gene therapies, or neuroprotective agents—impact these spatial patterns. What specific applications were you envisioning?

4

I was really looking forward to seeing DTI data incorporated here. There’s been a growing effort to combine those, like linking genetic markers to white matter alterations in Parkinson’s or Alzheimer’s. Hopefully, we’ll see that integration soon.